Author:
Jones Ronald N.,Sader Helio S.,Erwin Meredith E.
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference13 articles.
1. Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus;Blumberg;J Infect Dis,1991
2. In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolones;Chin;Antimicrob Agents Chemother,1988
3. Interpretive criteria for susceptibility testing of CI-960 (PD 127391, AM-1091), fleroxacin, lomefloxacin, and temafloxacin against Neisseria gonorrhoeae, including drug stability in GC agar media;Erwin;J Clin Microbiol,1992
4. Modifications for disk diffusion susceptibility testing criteria of clinafloxacin (CI-960, AM-1091, PD127371) and fleroxacin (RO 23-6240, AM-833) following studies with a challenge panel of ciprofloxacin-resistant clinical isolates;Jones;Diagn Microbiol Infect Dis,1994
5. Lomefloxacin (NY-198 or SC-47111): in vitro evaluations of a new fluoroquinolone;Jones;Diagn Microbiol Infect Dis,1989
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献